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OBJECTIVE—Aninternationalcommitteeof expertsrecommendedusingHbA1cfor diagnos-
tic testing for diabetes. Little is known about normal values of HbA1c in infants. The aim of this
study is to describe the distribution of HbA1c in 8- to 12-month-old nondiabetic infants.
RESEARCH DESIGN AND METHODS—HbA1c was measured in 86 infants participat-
inginthe GroningenExpert Center for Kids with Obesity (GECKO)-Drenthe birthcohortstudy.
Anthropometric measurements were performed at Well Baby Clinics. Data on parents and chil-
dren were collected prospectively using questionnaires.
RESULTS—HbA1c was normally distributed with a mean (SD) HbA1c level of 5.38% (0.24),
range 4.8–6.0% or 35.29 mmol/mol (2.65), range 29.1–42.1 mmol/mol. Age, sex, birth weight,
durationofbreastfeeding,anthropometricmeasurements,andmaternalBMIwerenotassociated
with HbA1c.
CONCLUSIONS—We found a normal distribution of HbA1c with a relatively high mean
HbA1c of 5.38%. No signiﬁcant association between risk factors for type 2 diabetes and HbA1c
levels was found.





with the prevalence of type 2 diabetes ris-
ing, an increase in use of HbA1c can be
expected (1). Accordingly, reference lev-
els for HbA1c will need to be developed
for all age groups. This study’s aim is to
describethedistributionofHbA1cinnon-
diabeticinfantsaged8–12months,andto
investigate predictors of HbA1c.
RESEARCH DESIGN AND
METHODS—The study population
consisted of 86 Dutch infants participat-
ing in the Groningen Expert Center for
Kids with Obesity (GECKO)-Drenthe
study. This population-based birth co-
hort study within the GECKO was de-
signed to examine risk factors for
developing childhood obesity (2). A
random subgroup (N =1 0 0 )o ft h i ss t u d y
population, aged about8 months, was in-
vited to participate in the current study.
Eighty-seven parents agreed to partici-
pate, and in eighty-six infants, an HbA1c
value could be assessed. This study was
approved by the Medical Ethics Commit-
tee of the University Medical Center
Groningen.
HbA1c was measured in a capillary
blood sample using a turbidimetric inhi-
bition immunoassay on a Cobas Integra
800 CTS analyzer (Roche Diagnostics,
Nederland BV, Almere, the Netherlands).
This method has been standardized
against the reference method of the Inter-
national Federation of Clinical Chemistry
and Laboratory Medicine (IFCC). Results
(mmol HbA1c/mol Hb) were converted to
units (% HbA1c) traceable to the Diabetes
Control and Complications Trial/National
Glycohemoglobin Standardization Pro-
gram (DCCT/NGSP) using the Roche
master-equation. Between-batch impreci-
sion (coefﬁcient of variation) was 2.1%
for a mean HbA1c of 5.5% and 1.9%
for a mean HbA1c of 10.6%.
Anthropometric measurements were
performed by trained staff at Well Baby
Clinics (2). Forty-eight percent of the in-
fants did not visit the Well Baby Clinic
within 2 weeks around blood sampling.
For these infants, weight, length, and
waist circumference were determined
by linear interpolation. Weight, waist cir-
cumference, and weight-for-length z-scores
were calculated using Growth Analyzer
3.5 (Growth Analyzer B.V., Rotterdam,
the Netherlands), based on Dutch refer-
encevalues(3,4).Growthvelocitywasde-
ﬁned as increase in weight between birth
and time of blood sampling, in grams per
week.
Data on gestational age, birth weight,
infant feeding, gestational diabetes, ma-
ternal BMI, and parental educational level
were obtained through questionnaires,
and missing data was obtained from
Well Baby Clinic ﬁles. Small for gesta-
tional age (SGA) and large for gestational
age (LGA) were deﬁned as birth weight
below the 10th percentile and above the
90th percentile, respectively, for gesta-
tionalagecomparedwithDutchreference
values by parity and sex (5).
We used ANOVA to test for differ-
encesinmeanHbA1cbetweengroupsand
linear regression to test the relationship
between continuous variables and
HbA1c. For all analyses, a level of signiﬁ-
cance of P , 0.05 was applied. Statistical
analyses were performed using SPSS 16.0
for Windows (SPSS, Chicago, IL).
RESULTS—Of the 86 infants included,
43 were girls and 43 were boys, with a
mean (SD) age of 9.42 months (1.14).
Mean (SD) HbA1c was 5.38% (0.24), range
was 4.8–6.0%, with a skewness (SE) of
0.215 (0.260) and a kurtosis (SE) of
20.004(0.514).AccordingtoIFCCvalues,
mean (SD) HbA1c was 35.29 mmol/mol
(2.65),range29.1–42.1mmol/mol(Fig.1).
HbA1cwasunrelatedtoageorsex.Birth
weight, growth velocity, anthropometric
ccccccccccccccccccccccccccccccccccccccccccccccccc
From the
1Department of Epidemiology, University Medical Center Groningen, University of Groningen,
Groningen, the Netherlands; and the
2Department of Pediatrics, Beatrix Children’s Hospital, University
Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Corresponding author: Hanneke Jansen, h.jansen@epi.umcg.nl.
Received 9 June 2010 and accepted 21 November 2010.
DOI: 10.2337/dc10-1100
© 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited,theuseiseducationalandnotforproﬁt,andtheworkisnotaltered.Seehttp://creativecommons.org/
licenses/by-nc-nd/3.0/ for details.
care.diabetesjournals.org DIABETES CARE, VOLUME 34, FEBRUARY 2011 403
Epidemiology/Health Services Research
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gestational diabetes, maternal BMI, and
parentaleducational levelwere all unasso-
ciated with HbA1c. HbA1c did not differ
between infants born SGA and infants
not born SGA, or between infants born
LGA and those not born LGA.
CONCLUSIONS—In this nondiabetic
infant population, aged 8–12 months,
HbA1c was normally distributed, with a
mean (SD) HbA1c of 5.38% (0.24), range
4.8–6.0%.
The mean HbA1c of 5.38% observed
in the current study is higher than that
found by studies in adults and older chil-
dren (6–9). Because HbA1c below 6% is
considered normal, the clinical relevance
of the difference between an HbA1c level
of 4.9% seen in adults and children, com-
pared with 5.4% in our study population,
is arguable. However, because the rate of
formationofHbA1c isdirectlyproportional
to ambient glucose concentration, our re-
sults could indicate higher glucose levels
in 8- to 12-month-old infants. The pre-
dominant fuel for human cells is glucose,
and survival of the brain depends on a
continuous supply, yet the brain cannot
synthesize glucose nor store more than a
few minutes supply as glycogen. The in-
fant brain is large relative to body mass
and, especially in this period, rapid brain
growth and differentiation takes place. To
meetthehighdemandforglucose,therate
of glucose production in infants and
young children is two to three times that
of older children and mature adults (10).
Thishighdemandforglucosebythebrain
and the subsequent higher rate of glucose
production might explain the higher
HbA1c levels observed in this study. An-
other explanation for the relatively high




tunately, glucose and insulin levels were
not assessed, so we could not test these
hypotheses.
At birth, between 55 and 65% of total
hemoglobin synthesis consists of HbF.
After birth, the production of the g-chain
declines to values of ,5% by the age of 6
months;normaladultHbFvaluesof,1%
are usually reached by age 1 year (13).
Because our study population’sa g e
ranged from8.1–12.3months,somewhat
higher levels of HbF might be expected.
Glycated HbF is not detected by the tur-
bidimetric inhibition immunoassay we
used; HbF, however, is included in total
hemoglobin determination. Because
HbA1c is expressed as a proportion, in-
fants with high amounts of HbF
(.10%) may have lower than expected
HbA1c values (14). However, this does
not explain the relatively high HbA1c lev-
els found in our study.
The life span of a fetal erythrocyte is
approximately 60–80 days, and the life
span of erythrocytes in infants is still less
than the 120-day life span of erythrocytes
in adults (15). A shorter life span for er-
ythrocytes should show lower HbA1c lev-
els instead of the higher levels we found.
To our knowledge, this is the ﬁrst
study describing the distribution of
HbA1c in nondiabetic infants. Compared
with known HbA1c levels in older chil-
dren, we found a relatively high mean
HbA1c of 5.38%. No signiﬁcant associa-
tionbetweenknownriskfactorsfortype2
diabetes and HbA1c was found.
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